PACIRA BIOSCIENCES IN
17.42
25-November-24 16:45:01
15 minutes delayed
Stocks
-0.13
-0.74%
Today's range
17.41 - 18.09
ISIN
N/A
Source
NASDAQ
-
Pacira BioSciences Reports Second Quarter 2022 Financial Results
03 Aug 2022 08:00:03 By Nasdaq GlobeNewswire
-
02 Aug 2022 08:00:02 By Nasdaq GlobeNewswire
-
Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022
27 Jul 2022 08:00:01 By Nasdaq GlobeNewswire
-
Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million
14 Jul 2022 07:30:00 By Nasdaq GlobeNewswire
-
16 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
14 Jun 2022 08:00:00 By Nasdaq GlobeNewswire
-
Pacira BioSciences to Participate in Fireside Chat at the Jefferies Healthcare Conference
02 Jun 2022 08:00:02 By Nasdaq GlobeNewswire
-
12 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
Pacira BioSciences to Present at Two Healthcare Conferences in May
10 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
Pacira BioSciences Reports First Quarter 2022 Financial Results
04 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
Pacira to Report First Quarter 2022 Financial Results on Wednesday May 4, 2022
27 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
12 Apr 2022 08:00:01 By Nasdaq GlobeNewswire
-
05 Apr 2022 08:00:02 By Nasdaq GlobeNewswire
-
15 Mar 2022 08:00:03 By Nasdaq GlobeNewswire
-
Pacira BioSciences to Participate in Fireside Chat at the Barclays Global Healthcare Conference
09 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results
24 Feb 2022 08:00:02 By Nasdaq GlobeNewswire
-
Pacira to Report 2021 Financial Results on Thursday February 24, 2022
16 Feb 2022 08:00:02 By Nasdaq GlobeNewswire
-
15 Feb 2022 08:00:02 By Nasdaq GlobeNewswire
-
Pacira Reports Preliminary Unaudited Total Revenue for 2021 of $540.7 Million to $541.7 Million
06 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
Pacira BioSciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
03 Jan 2022 08:00:01 By Nasdaq GlobeNewswire